ABVC Abvc Biopharma Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ABVC

Price (delayed)

$1.05

Market cap

$11.09M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.43

Enterprise value

$12.65M

Highlights
Abvc Biopharma's EPS has surged by 53% YoY and by 32% QoQ
ABVC's net income is up by 36% year-on-year and by 14% since the previous quarter
ABVC's equity has soared by 171% year-on-year but it is down by 8% since the previous quarter
The gross profit has dropped by 148% since the previous quarter and by 122% year-on-year
The revenue has dropped by 84% year-on-year and by 79% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: OCX OGEN OLMA OMER

Key stats

What are the main financial stats of ABVC
Market
Shares outstanding
10.56M
Market cap
$11.09M
Enterprise value
$12.65M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.91
Price to sales (P/S)
29.87
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
82.99
Earnings
Revenue
$152,430
EBIT
-$7.77M
EBITDA
-$7.74M
Free cash flow
-$4.26M
Per share
EPS
-$2.43
Free cash flow per share
-$0.98
Book value per share
$1.16
Revenue per share
$0.04
TBVPS
$3.34
Balance sheet
Total assets
$14.49M
Total liabilities
$6.36M
Debt
$2.28M
Equity
$8.39M
Working capital
-$4.28M
Liquidity
Debt to equity
0.27
Current ratio
0.28
Quick ratio
0.26
Net debt/EBITDA
-0.2
Margins
EBITDA margin
-5,076.3%
Gross margin
-98.1%
Net margin
-6,898.7%
Operating margin
-5,390.3%
Efficiency
Return on assets
-82.3%
Return on equity
-224%
Return on invested capital
-76.3%
Return on capital employed
-90.7%
Return on sales
-5,095%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ABVC stock price

How has the Abvc Biopharma stock price performed over time
Intraday
2.94%
1 week
-8.7%
1 month
-9.48%
1 year
-84.12%
YTD
-9.48%
QTD
-19.85%

Financial performance

How have Abvc Biopharma's revenue and profit performed over time
Revenue
$152,430
Gross profit
-$149,607
Operating income
-$8.22M
Net income
-$10.52M
Gross margin
-98.1%
Net margin
-6,898.7%
The gross profit has dropped by 148% since the previous quarter and by 122% year-on-year
The revenue has dropped by 84% year-on-year and by 79% since the previous quarter
ABVC's operating income is up by 46% YoY and by 12% QoQ
ABVC's net income is up by 36% year-on-year and by 14% since the previous quarter

Growth

What is Abvc Biopharma's growth rate over time

Valuation

What is Abvc Biopharma stock price valuation
P/E
N/A
P/B
0.91
P/S
29.87
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
82.99
Abvc Biopharma's EPS has surged by 53% YoY and by 32% QoQ
ABVC's equity has soared by 171% year-on-year but it is down by 8% since the previous quarter
The revenue has dropped by 84% year-on-year and by 79% since the previous quarter
The P/S is 48% higher than the last 4 quarters average of 20.2

Efficiency

How efficient is Abvc Biopharma business performance
ABVC's ROIC has soared by 62% YoY and by 29% QoQ
The ROA has grown by 42% year-on-year and by 23% since the previous quarter
The company's return on equity rose by 38% QoQ and by 12% YoY

Dividends

What is ABVC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ABVC.

Financial health

How did Abvc Biopharma financials performed over time
ABVC's total assets is 128% greater than its total liabilities
The quick ratio has dropped by 57% since the previous quarter and by 49% year-on-year
ABVC's total assets has surged by 51% year-on-year but it is down by 13% since the previous quarter
The debt is 73% less than the equity
ABVC's equity has soared by 171% year-on-year but it is down by 8% since the previous quarter
The debt to equity has dropped by 73% year-on-year and by 27% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.